Cautious Momentum: Biopharma Review and Outlook (Pharmaceutical Executive March 2026)
Young & Partners shares with Pharmaceutical Executive on our analysis of M&A trends for Pharmaceuticals and Biotech in 2025 and the future outlook of M&A in 2026.
Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)
Young & Partners is interviewed by Chemical Week on our analysis of M&A trends in 2025 and the future outlook in 2026.
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)
Young & Partners reports on our analysis of chemical stock market and financing trends for 2025 and the future outlook in 2026.
Cautious Momentum: Biopharma Review and Outlook (Pharmaceutical Executive March 2026)
Young & Partners shares with Pharmaceutical Executive on our analysis of M&A trends for Pharmaceuticals and Biotech in 2025 and the future outlook of M&A in 2026.
Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)
Young & Partners is interviewed by Chemical Week on our analysis of M&A trends in 2025 and the future outlook in 2026.
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)
Young & Partners reports on our analysis of chemical stock market and financing trends for 2025 and the future outlook in 2026.
Cautious Momentum: Biopharma Review and Outlook (Pharmaceutical Executive March 2026)
Young & Partners shares with Pharmaceutical Executive on our analysis of M&A trends for Pharmaceuticals and Biotech in 2025 and the future outlook of M&A in 2026.
Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)
Young & Partners is interviewed by Chemical Week on our analysis of M&A trends in 2025 and the future outlook in 2026.
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)
Young & Partners reports on our analysis of chemical stock market and financing trends for 2025 and the future outlook in 2026.
Cautious Momentum: Biopharma Review and Outlook (Pharmaceutical Executive March 2026)
Young & Partners shares with Pharmaceutical Executive on our analysis of M&A trends for Pharmaceuticals and Biotech in 2025 and the future outlook of M&A in 2026.
Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)
Young & Partners is interviewed by Chemical Week on our analysis of M&A trends in 2025 and the future outlook in 2026.
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)
Young & Partners reports on our analysis of chemical stock market and financing trends for 2025 and the future outlook in 2026.